ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2383

Frailty and Risk of Fractures in Patients with Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI)

Guowei Li1, Xiuying Li2, Angela Cesta3, Arthur Lau4, Claire Bombardier3 and J Adachi5, 1Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada, 2University of Toronto, TORONTO, ON, Canada, 3Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 450 Charlton Avenue East, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 5St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: fracture risk and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Measuring the degree of frailty can help screen, quantify and predict future risk of adverse health outcomes at a clinical research level and at a healthcare policy level. The evidence assessing the relationship between frailty and risk of adverse health outcomes in rheumatoid arthritis (RA) patients remains limited and sparse in the literature. Therefore we aimed to assess the relationship between frailty and risk of fractures in patients with RA, using data from the Ontario Best Practices Research Initiative (a clinical registry of patients with RA in Ontario, Canada).

Methods:

Patients’ data were collected from the participating rheumatologists every 6 months, and from OBRI interviewers every 3 months in the first two years and every 6 months afterwards. The primary outcome was incident fractures during follow-up that led to a hospitalization or emergency room (ER) visit. Frailty was measured as a frailty index (FI) of deficit accumulation that included 32 health-related deficits consisting of 17 co-morbidities, 16 symptoms and signs, and 9 activities of daily living. The FI ranged from 0 to 1, with a higher FI indicating higher frailty. Student’s t-test was used for comparison of FI between patients with and without a fracture during follow-up.

Results:

There were 3,153 patients (78% females, mean age 57.5 years) included for analyses. Patients’ mean FI at baseline was 0.21 (standard deviation [SD]: 0.17), and the age-invariant 99% upper limit was 0.52. During the mean follow-up of 3.7 years, there were 125 incident fractures reported. As shown in Table 1, patients experiencing a fracture were older, more likely to be females, and had a longer RA duration, compared to patients without a fracture. The FI was significantly higher in patients with a fracture compared to controls (0.25 vs. 0.21, p < 0.001).

Conclusion:

RA patients experiencing an incident fracture were significantly frailer than patients who did not experience a fracture. Measuring the grades of frailty may assist with the assessment and management of RA patients to predict and reduce their fracture risk.

Table 1. Comparison of baseline characteristics between RA patients with a fracture leading to hospitalization or ER visit and patients without fractures during follow-up

Baseline characteristics

Incident fracture that lead to a hospitalization or ER visit

Yes (n =125)

No (n = 3,028)

P value

Age: mean (SD), years

61.9 (11.9)

57.3 (12.9)

< 0.001

Female: n (%)

109 (87%)

2,319 (78%)

0.013

RA duration: mean (SD), years

11.6 (11.4)

8.2 (9.7)

0.002

BMI: mean (SD), kg/m2

26.5 (5.0)

27.0 (5.6)

0.33

Family history of RA: n (%)

49 (39%)

970 (32%)

0.11

Smoking: n (%)

20 (16%)

504 (17%)

0.82

Alcohol drinking: n (%)

34 (27%)

828 (27%)

0.93

Osteoporosis medication use: n (%)

44 (35%)

826 (27%)

0.059

FI: mean (SD)

0.25 (0.12)

0.21 (0.12)

< 0.001

ER = emergency room; SD = standard deviation; RA = rheumatoid arthritis; BMI = body mass index; FI = frailty index


Disclosure: G. Li, None; X. Li, None; A. Cesta, None; A. Lau, None; C. Bombardier, None; J. Adachi, Amgen, Eli Lilly, Merck, 2,Amgen, Eli Lilly, Merck, 5,International Osteoporosis Foundation Board of Directors, Scientific Advisor; Osteoporosis Canada Past-President, 6,Amgen, 8.

To cite this abstract in AMA style:

Li G, Li X, Cesta A, Lau A, Bombardier C, Adachi J. Frailty and Risk of Fractures in Patients with Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI) [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/frailty-and-risk-of-fractures-in-patients-with-rheumatoid-arthritis-data-from-the-ontario-best-practices-research-initiative-obri/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/frailty-and-risk-of-fractures-in-patients-with-rheumatoid-arthritis-data-from-the-ontario-best-practices-research-initiative-obri/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology